Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Acrux ( (AU:ACR) ).
Acrux Ltd has announced a change in the interest of its director, Don Brumley, who has increased his holdings by acquiring 448,334 ordinary shares through the exercise of vested unlisted rights issued in 2024. This change reflects a strategic move by the director to increase his stake in the company, potentially signaling confidence in Acrux’s future performance and aligning his interests more closely with those of the shareholders.
More about Acrux
Acrux Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of innovative drug delivery solutions. The company primarily offers products that enhance the delivery of medications through the skin, targeting various therapeutic areas and aiming to improve patient outcomes.
Average Trading Volume: 271,212
Technical Sentiment Signal: Sell
Current Market Cap: A$9.78M
Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.